{"id":"NCT03649477","sponsor":"Levo Therapeutics, Inc.","briefTitle":"Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome","officialTitle":"Phase 3, Randomized, Double-Blind, Placebo-Controlled, 8-week Clinical Study to Assess the Efficacy, Safety, and Tolerability, of Intranasal Carbetocin (LV-101) in Prader-Willi Syndrome (PWS) With Long Term Follow-Up (CARE-PWS)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-11-20","primaryCompletion":"2020-05-13","completion":"2022-07-09","firstPosted":"2018-08-28","resultsPosted":"2021-11-17","lastUpdate":"2022-07-26"},"enrollment":130,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Prader-Willi Syndrome"],"interventions":[{"type":"DRUG","name":"3.2 mg intranasal carbetocin","otherNames":["LV-101"]},{"type":"DRUG","name":"9.6 mg intranasal carbetocin","otherNames":["LV-101"]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"3.2 mg of LV-101","type":"EXPERIMENTAL"},{"label":"9.6 mg of LV-101","type":"EXPERIMENTAL"}],"summary":"This Phase 3 study is designed to test the effectiveness of intranasal carbetocin (LV-101) in participants with Prader-Willi syndrome (PWS). Carbetocin is an oxytocin analog (a man-made chemical that is like oxytocin). This study will also evaluate the safety and tolerability of LV-101.","primaryOutcome":{"measure":"Hyperphagia Behavior","timeFrame":"Baseline to Week 8","effectByArm":[{"arm":"9.6 mg of LV-101","deltaMin":-3.439,"sd":null},{"arm":"3.2 mg of LV-101","deltaMin":-5.372,"sd":null},{"arm":"Placebo","deltaMin":-2.237,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.3493"},{"comp":"OG001 vs OG002","p":"0.0162"}]},"eligibility":{"minAge":"7 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":10},"locations":{"siteCount":24,"countries":["United States","Australia","Canada"]},"refs":{"pmids":["36633570"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":44},"commonTop":["Flushing","Headache","Epistaxis","Diarrhea","Upper respiratory tract infection"]}}